http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190130519-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate | 2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0733009f8f9a5ca1a98ec67cc0a81a8d |
| publicationDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190130519-A |
| titleOfInvention | Method for treating malignant tumor by azabicyclo compound |
| abstract | The provision of the treatment of malignant tumor by the aza bicyclic compound which especially reduced the eye disorder. A method for treating malignant tumors, comprising: 3-ethyl-4- [3- (1-methylethyl) -4- [4- (1-methyl-1H-pyrazole- for a patient in need thereof 4-yl) -1H-imidazol-1-yl] -1H-pyrazolo [3,4-b] pyridin-1-yl] benzamide (Compound 1) or a salt thereof according to the dosing schedule Including, The dosing regimen comprises setting a drug holiday of at least two days after the daily administration of Compound 1 or a salt thereof as an amount of Compound 1 at a dose of 40 mg / body / day to 240 mg / body / day, Way. |
| priorityDate | 2018-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.